Essex Investment Management Co. LLC bought a new stake in CryoPort Inc (NASDAQ:CYRX) during the fourth quarter, HoldingsChannel.com reports. The firm bought 35,399 shares of the consumer goods maker’s stock, valued at approximately $304,000.
Several other hedge funds have also modified their holdings of the business. Thompson Davis & CO. Inc. boosted its holdings in shares of CryoPort by 74.5% in the 4th quarter. Thompson Davis & CO. Inc. now owns 30,100 shares of the consumer goods maker’s stock valued at $259,000 after purchasing an additional 12,850 shares in the last quarter. US Bancorp DE boosted its holdings in shares of CryoPort by 100.9% in the 4th quarter. US Bancorp DE now owns 25,487 shares of the consumer goods maker’s stock valued at $219,000 after purchasing an additional 12,803 shares in the last quarter. Taylor Wealth Management Partners boosted its holdings in shares of CryoPort by 5.6% in the 4th quarter. Taylor Wealth Management Partners now owns 415,575 shares of the consumer goods maker’s stock valued at $3,570,000 after purchasing an additional 21,935 shares in the last quarter. Creative Planning acquired a new stake in shares of CryoPort in the 4th quarter valued at $5,176,000. Finally, Bank of Montreal Can acquired a new stake in shares of CryoPort in the 4th quarter valued at $142,000. 20.22% of the stock is currently owned by hedge funds and other institutional investors.
Separately, Roth Capital assumed coverage on CryoPort in a report on Thursday, November 30th. They issued a “buy” rating and a $12.50 target price on the stock. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. CryoPort currently has a consensus rating of “Buy” and an average price target of $33.50.
WARNING: “Essex Investment Management Co. LLC Invests $304,000 in CryoPort Inc (CYRX) Stock” was reported by Community Financial News and is the property of of Community Financial News. If you are accessing this piece on another site, it was stolen and republished in violation of United States and international copyright law. The legal version of this piece can be accessed at https://www.com-unik.info/2018/02/09/essex-investment-management-co-llc-invests-304000-in-cryoport-inc-cyrx-stock.html.
CryoPort Company Profile
Cryoport, Inc (Cryoport) is a provider of cryogenic logistics solutions to the life sciences industry through its purpose-built packaging, information technology and specialized cold chain logistics expertise. The Company provides logistics solutions for biologic materials, such as immunotherapies, stem cells, chimeric antigen receptors (CAR)-T cells, and reproductive cells for clients.
Want to see what other hedge funds are holding CYRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CryoPort Inc (NASDAQ:CYRX).
Receive News & Ratings for CryoPort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort and related companies with MarketBeat.com's FREE daily email newsletter.